BioRestorative Therapies Inc (BRTX)

[Hole shot King]

AI Overview
Phase 3 clinical trials typically last 1 to 4 years, sometimes longer (up to 5 years), as they involve large patient groups (hundreds to thousands) to confirm effectiveness, monitor long-term effects, compare against existing treatments, and detect rarer side effects before regulatory approval. The exact duration depends on the disease (chronic conditions take longer), trial complexity (like primary endpoints and sample size), and recruitment speed.

no rush given BRTX track record 🙈